Evaluation of Risk-Adjusted Home Time After Acute Myocardial Infarction as a Novel Hospital-Level Performance Metric for Medicare Beneficiaries.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
07 07 2020
Historique:
pubmed: 16 5 2020
medline: 31 8 2021
entrez: 16 5 2020
Statut: ppublish

Résumé

The utility of 30-day risk-standardized readmission rate (RSRR) as a hospital performance metric has been a matter of debate. Home time is a patient-centered outcome measure that accounts for rehospitalization, mortality, and postdischarge care. We aim to characterize risk-adjusted 30-day home time in patients with acute myocardial infarction (AMI) as a hospital-level performance metric and to evaluate associations with 30-day RSRR, 30-day risk-standardized mortality rate (RSMR), and 1-year RSMR. The study included 984 612 patients with AMI hospitalization across 2379 hospitals between 2009 and 2015 derived from 100% Medicare claims data. Home time was defined as the number of days alive and spent outside of a hospital, skilled nursing facility, or intermediate-/long-term acute care facility 30 days after discharge. Correlations between hospital-level risk-adjusted 30-day home time and 30-day RSRR, 30-day RSMR, and 1-year RSMR were estimated with the Pearson correlation. Reclassification in hospital performance using 30-day home time versus 30-day RSRR and 30-day RSMR was also evaluated. Median hospital-level risk-adjusted 30-day home time was 24.0 days (range, 15.3-29.0 days). Hospitals with higher home time were more commonly academic centers, had available cardiac surgery and rehabilitation services, and had higher AMI volume and percutaneous coronary intervention use during the AMI hospitalization. Of the mean 30-day home time days lost, 58% were to intermediate-/long-term care or skilled nursing facility stays (4.7 days), 30% to death (2.5 days), and 12% to readmission (1.0 days). Hospital-level risk-adjusted 30-day home time was inversely correlated with 30-day RSMR ( Thirty-day home time for patients with AMI can be assessed as a hospital-level performance metric with the use of Medicare claims data. It varies across hospitals, is associated with postdischarge readmission and mortality outcomes, and meaningfully reclassifies hospital performance compared with the 30-day RSRR and 30-day RSMR metrics.

Sections du résumé

BACKGROUND
The utility of 30-day risk-standardized readmission rate (RSRR) as a hospital performance metric has been a matter of debate. Home time is a patient-centered outcome measure that accounts for rehospitalization, mortality, and postdischarge care. We aim to characterize risk-adjusted 30-day home time in patients with acute myocardial infarction (AMI) as a hospital-level performance metric and to evaluate associations with 30-day RSRR, 30-day risk-standardized mortality rate (RSMR), and 1-year RSMR.
METHODS
The study included 984 612 patients with AMI hospitalization across 2379 hospitals between 2009 and 2015 derived from 100% Medicare claims data. Home time was defined as the number of days alive and spent outside of a hospital, skilled nursing facility, or intermediate-/long-term acute care facility 30 days after discharge. Correlations between hospital-level risk-adjusted 30-day home time and 30-day RSRR, 30-day RSMR, and 1-year RSMR were estimated with the Pearson correlation. Reclassification in hospital performance using 30-day home time versus 30-day RSRR and 30-day RSMR was also evaluated.
RESULTS
Median hospital-level risk-adjusted 30-day home time was 24.0 days (range, 15.3-29.0 days). Hospitals with higher home time were more commonly academic centers, had available cardiac surgery and rehabilitation services, and had higher AMI volume and percutaneous coronary intervention use during the AMI hospitalization. Of the mean 30-day home time days lost, 58% were to intermediate-/long-term care or skilled nursing facility stays (4.7 days), 30% to death (2.5 days), and 12% to readmission (1.0 days). Hospital-level risk-adjusted 30-day home time was inversely correlated with 30-day RSMR (
CONCLUSIONS
Thirty-day home time for patients with AMI can be assessed as a hospital-level performance metric with the use of Medicare claims data. It varies across hospitals, is associated with postdischarge readmission and mortality outcomes, and meaningfully reclassifies hospital performance compared with the 30-day RSRR and 30-day RSMR metrics.

Identifiants

pubmed: 32408764
doi: 10.1161/CIRCULATIONAHA.119.044765
pmc: PMC9364938
mid: NIHMS1599378
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-39

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL122527
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG055663
Pays : United States

Références

Neurology. 2017 Nov 7;89(19):1970-1976
pubmed: 29021355
Inquiry. 2019 Jan-Dec;56:46958018817994
pubmed: 30894035
Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):243-52
pubmed: 21406673
Circulation. 2006 Apr 4;113(13):1683-92
pubmed: 16549637
JAMA Cardiol. 2017 Jul 1;2(7):723-731
pubmed: 28445559
JACC Heart Fail. 2016 Dec;4(12):935-946
pubmed: 27908393
N Engl J Med. 2010 Mar 25;362(12):1110-8
pubmed: 20335587
JAMA Netw Open. 2018 Sep 7;1(5):e182776
pubmed: 30646175
Circ Cardiovasc Interv. 2019 Jan;12(1):e006928
pubmed: 30608883
JAMA Cardiol. 2020 Feb 1;5(2):136-145
pubmed: 31913411
Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e005083
pubmed: 30562071
JAMA. 2014 Oct 15;312(15):1542-51
pubmed: 25321909
Eur Heart J Qual Care Clin Outcomes. 2020 Jan 1;6(1):62-71
pubmed: 31124567
JAMA Cardiol. 2020 May 1;5(5):515-521
pubmed: 32074242
JACC Heart Fail. 2020 Jan;8(1):1-11
pubmed: 31606360
J Am Coll Cardiol. 2019 Jul 16;74(2):219-234
pubmed: 31296295
Stroke. 2016 Mar;47(3):836-42
pubmed: 26892279
JAMA Cardiol. 2018 Jan 1;3(1):44-53
pubmed: 29128869
JAMA. 2013 Sep 25;310(12):1227-8
pubmed: 24008265
N Engl J Med. 2010 Jul 15;363(3):297-8
pubmed: 20647209
Stroke. 2008 Jan;39(1):231-3
pubmed: 18032742
JAMA Netw Open. 2018 Sep 7;1(5):e182777
pubmed: 30646181
JAMA. 2018 Dec 25;320(24):2542-2552
pubmed: 30575880
Disabil Rehabil. 2020 Feb;42(3):419-425
pubmed: 30274531
J Hosp Med. 2015 Oct;10(10):670-7
pubmed: 26149225
Health Aff (Millwood). 2013 May;32(5):864-72
pubmed: 23650319
JACC Heart Fail. 2018 Jul;6(7):607-609
pubmed: 29957194
J Am Geriatr Soc. 2019 Feb;67(2):347-351
pubmed: 30578532
J Am Coll Cardiol. 2018 Jun 12;71(23):2643-2652
pubmed: 29880124
JAMA. 2016 Dec 27;316(24):2647-2656
pubmed: 28027367
JAMA. 2018 Apr 17;319(15):1616-1617
pubmed: 29677292
JAMA Cardiol. 2017 Feb 1;2(2):200-203
pubmed: 27784054

Auteurs

Ambarish Pandey (A)

Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX (A.P., N.K.).

Neil Keshvani (N)

Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX (A.P., N.K.).

Mary S Vaughan-Sarrazin (MS)

Center for Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Medical Center, Iowa (M.S.V.-S., Y.G., S.G.).
Department of Internal Medicine (M.S.V.-S., Y.G., S.G.), Carver College of Medicine, University of Iowa, Iowa City.

Yubo Gao (Y)

Center for Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Medical Center, Iowa (M.S.V.-S., Y.G., S.G.).
Department of Internal Medicine (M.S.V.-S., Y.G., S.G.), Carver College of Medicine, University of Iowa, Iowa City.

Saket Girotra (S)

Center for Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Medical Center, Iowa (M.S.V.-S., Y.G., S.G.).
Department of Internal Medicine (M.S.V.-S., Y.G., S.G.), Carver College of Medicine, University of Iowa, Iowa City.
Division of Cardiovascular Diseases, Department of Internal Medicine (S.G.)., Carver College of Medicine, University of Iowa, Iowa City.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH